<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">epidemiology</journal-id><journal-title-group><journal-title xml:lang="ru">Эпидемиология и Вакцинопрофилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Epidemiology and Vaccinal Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-3046</issn><issn pub-type="epub">2619-0494</issn><publisher><publisher-name>«Numicom» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31631/2073-3046-2024-23-3-98-106</article-id><article-id custom-type="elpub" pub-id-type="custom">epidemiology-2018</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРАКТИЧЕСКИЕ АСПЕКТЫ ЭПИДЕМИОЛОГИИ И ВАКЦИНОПРОФИЛАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRACTICAL ASPECTS OF EPIDEMIOLOGY AND VACCINE PREVENTION</subject></subj-group></article-categories><title-group><article-title>Риск заражения COVID-­19 работников крупного противотуберкулезного учреждения Москвы: результаты анкетирования</article-title><trans-title-group xml:lang="en"><trans-title>Risk of COVID­-19 Infection among Employees of a Large Anti­tuberculosis Institution in Moscow: Survey Results</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4552-5022</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богородская</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogorodskaya</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Михайловна Богородская – директор; профессор кафедры фтизиатрии</p><p>Москва</p><p>+7 (925) 381-02-18</p></bio><bio xml:lang="en"><p>Elena M. Bogorodskaya – Director; Professor of the Department of Phthisiology</p><p>Moscow</p><p>+7 (925) 381-02-18</p></bio><email xlink:type="simple">el_bogorodskaya@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ноздреватых</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nozdrevatykh</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игорь Васильевич Ноздреватых – заместитель главного врача по санитарно-эпидемиологическим вопросам</p><p>Москва</p><p>+7 (916) 582-77-69</p></bio><bio xml:lang="en"><p>Igor V. Nozdrevatykh – Deputy Chief Physician for Sanitary and Epidemiological Issues</p><p>Moscow</p><p>+7 (916) 582-77-69</p></bio><email xlink:type="simple">nozdr27@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-0690-7928</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Христофорова</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Khristoforova</surname><given-names>E. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Леонидовна Христофорова – заведующая отделом эпидемиологии, врач-эпидемиолог</p><p>107014, Москва, ул. Стромынка, д.10</p><p>+7 (499) 268-00-05</p><p>+7 (905) 137-73-40</p><p>факс +7 (499) 785-20-82</p><p>e-mail: celene@yandex.ru</p></bio><bio xml:lang="en"><p>Elena L. Khristoforova – Head of the Department of epidemiology epidemiologist</p><p>Moscow</p><p>+7 (905) 137-73-40</p></bio><email xlink:type="simple">cbt@zdrav.mos.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9767-4022</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белиловский</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Belilovsky</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евгений Михайлович Белиловский – заведующий отделом эпидемиологического мониторинга туберкулеза</p><p>Москва</p><p>+7 (916) 124-04-92</p></bio><bio xml:lang="en"><p>Evgeny M. Belilovskiy – Head of the Department of epidemiological TB surveillance</p><p>Moscow</p><p>+7 (916) 124-04-92</p></bio><email xlink:type="simple">belilo5@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Московский городской научно­-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Research and Clinical Center for TB Control, Moscow Department of Health; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Московский городской научно­-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Research and Clinical Center for TB Control, Moscow Department of Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>10</day><month>07</month><year>2024</year></pub-date><volume>23</volume><issue>3</issue><fpage>98</fpage><lpage>106</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Богородская Е.М., Ноздреватых И.В., Христофорова Е.Л., Белиловский Е.М., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Богородская Е.М., Ноздреватых И.В., Христофорова Е.Л., Белиловский Е.М.</copyright-holder><copyright-holder xml:lang="en">Bogorodskaya E.M., Nozdrevatykh I.V., Khristoforova E.L., Belilovsky E.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epidemvac.ru/jour/article/view/2018">https://www.epidemvac.ru/jour/article/view/2018</self-uri><abstract><p>Актуальность. Изучение опыта работы в условиях COVID-19 позволяет более эффективно оценить функционирование противоэпидемических мероприятий при появлении или угрозе возникновения новых пандемий, вызванных в том числе и новыми возбудителями. Риск заражения COVID-19 среди работников медицинских организаций (МО) выше по сравнению с остальным населением мегаполиса, что определяет необходимость разработки в медицинской организации дополнительных мер для защиты сотрудников. Своевременная оценка рисков и мер профилактики в условиях пандемии позволяют выстроить систему защиты медицинских учреждений от возникновения различных биологических угроз при оказании медицинской помощи. Цель. Оценка рисков заражения COVID-19 работников крупной противотуберкулезной МО мегаполиса. Материалы и методы. Проведено анкетирование работников крупной противотуберкулезной медицинской организации Москвы. Опрос проводился по 46 ключевым вопросам эпиданамнеза, выполнения требований санитарно-противоэпидемического режима, предполагаемым источникам инфицирования, прогностическим рискам возникновения и течения COVID-19. С 1 августа по 1 октября 2022 г. было опрошено 1225 работников организации (43,8% общей численности). Анкетирование проводилось на добровольной основе и было анонимным. При ответе на вопросы участники предоставляли информацию о демографических факторах (возраст, пол), месте фактического проживания, о факте заболевания COVID-19, кратности лабораторного обследования на SARS-CoV-2, иммунизации против COVID-19, возможных местах контакта с больными COVID-19, использовании средств индивидуальной защиты (СИЗ) в быту и на работе, регулярности применения кожных антисептиков, а также иную информацию, которая позволила бы установить риски инфицирования работников в быту и на работе. Для оценки рисков инфицирования респонденты были разделены на две группы в зависимости от наличия положительного теста на SARS-CoV-2 (I группа) или его отсутствия (II группа) на 1.10.2022 г. Материалом для тестирования служили мазки из носо/ ротоглотки. Обследование сотрудников проводилось на базе лаборатории противотуберкулезной медицинской организации, а также в других аккредитованных лабораториях мегаполиса молекулярно-генетическим методом, а с февраля 2022 г. – также экспресс-методом, определяющим антиген SARS-CoV-2. Результаты и обсуждение. Среди участников анкетирования и согласно анкетным данным COVID-19 перенесли 797 сотрудников, а 138 (17,3%) из их числа имели повторные случаи заболевания. Были выявлены факторы, повышающие риск заболевания COVID-19 персонала противотуберкулезной медицинской организации, принимающей непосредственное участие в оказании помощи пациентам, инфицированным SARS-CoV-2. Анализ результатов анкетирования выявил определяющие ситуацию по COVID-19 в МО факторы: кратность обследования на COVID-19; регулярность использования кожных антисептиков; контакты с источниками инфекции; ношение очков для коррекции зрения; использование общественного транспорта; прием пищи на работе; постоянное информирование сотрудников МО о мерах профилактики в условиях пандемии. Вывод. Подтверждена необходимость изучения рисков заражения COVID-19 работников медицинской организации и разработка на их основе комплекса дополнительных мер противоэпидемической защиты.</p></abstract><trans-abstract xml:lang="en"><p>Relevance. Studying the experience of working under the conditions of COVID-19 allows us to more effectively assess the functioning of anti-epidemic measures in the event of the occurrence or threat of new pandemics, including those caused by new pathogens. The risk of contracting COVID-19 among employees of medical organizations is higher compared to the rest of the population of the metropolis, which determines the need to develop additional measures in medical organizations to protect workers. Timely assessment of risks and preventive measures during a pandemic allow building a system to protect medical institutions from various biological threats when providing medical care. Aim. Assessment of the risks of contracting COVID-19 among employees of a large anti-tuberculosis medical organization in a metropolis. Materials &amp; Methods. A survey of employees of a large anti-tuberculosis medical organization in Moscow was conducted. The survey was conducted on 46 key questions of epidemiological history, compliance with the requirements of the sanitary and anti-epidemic regime, alleged sources of infection, prognostic risks of the occurrence and course of COVID-19. During the period from August 1 to October 1, 2022, 1225 employees of the institution were surveyed (43.8% of the total number). The survey was conducted on a voluntary basis and was anonymous. When answering questions, participants provided information about demographic factors (age, gender), place of actual residence, the fact of contracting a new coronavirus infection, frequency of laboratory testing for SARS-CoV-2, immunization against COVID-19, possible places of contact with patients with COVID-19, the use of personal protective equipment (PPE) at home and at work, the regular use of skin antiseptics, as well as other information that allowed us to establish the risks of infection of workers at home and at work. To assess the risks of infection, respondents were divided into two groups depending on the presence of a positive test for SARS-CoV-2 (group I) or its absence (group II) as of October 1, 2022. The material for testing was nasal/oropharyngeal swabs. The research of employees was carried out on the basis of the laboratory of the anti-tuberculosis medical organization, as well as in other accredited laboratories of the metropolis using the molecular genetic method, and since February 2022 also using the express method that determines the SARS-CoV-2 antigen. Results. Among the survey participants and according to the questionnaire data, 797 employees suffered from the new coronavirus infection COVID-19, and 138 (17.3%) of them had repeated cases of the disease. Factors that increase the risk of COVID-19 among personnel of anti-tuberculosis medical organizations directly involved in the fight against the new coronavirus infection have been identified. The results of the study demonstrated that important factors influencing the incidence of workers were the frequency of examination for COVID-19, the regular use of skin antiseptics, contact with sources of infection, the use of glasses for vision correction, the use of public transport and eating at work. Conclusion. The need to study the risks of contracting COVID-19 among employees of medical organization and, based on them, develop a set of additional anti-epidemic protection measures was confirmed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>заболеваемость</kwd><kwd>COVID-19</kwd><kwd>профессиональная заболеваемость</kwd><kwd>риск COVID-19</kwd></kwd-group><kwd-group xml:lang="en"><kwd>incidence of COVID-19</kwd><kwd>occupational morbidity</kwd><kwd>risk of contracting COVID-19 among employees in a tuberculosis facility</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson R., Heesterbeek H., Klinkenberg D., et al. How will country-based mitigation measures influence the course of the COVID-19 epidemic. Lancet. 2020 Mar 21;395(10228):931–34. doi: 10.1016/S0140-6736(20)30567-5.</mixed-citation><mixed-citation xml:lang="en">Anderson R, Heesterbeek H, Klinkenberg D, et al. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020 Mar 21;395(10228):931–934. doi: 10.1016/S0140-6736(20)30567-5.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Johns Hopkins University of Medicine. Coronavirus resource center. Доступно на: https://coronavirus.jhu.edu/map.html (Дата обращения 25.01.2024).</mixed-citation><mixed-citation xml:lang="en">Johns Hopkins University of Medicine. Coronavirus resource center. Available at:: https://coronavirus.jhu.edu/map.html (Дата обращения 25.01.2024).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Black J., Bailey C., Przewrocka J., et al. COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet. 2020 May 2;395(10234):1418–1420. doi: 10.1016/S0140-6736(20)30917-X4.</mixed-citation><mixed-citation xml:lang="en">Black J, Bailey C, Przewrocka J, et al. COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet. 2020 May 2;395(10234):1418–1420. doi: 10.1016/S0140-6736(20)30917-X4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">CDC COVID-19 Response Team. Characteristics of health care personnel with COVID-19: United States, February 12–April 9, 2020. Morbidity and Mortality Weekly Report. 2020 Apr 17; 69: 477–81. doi: 10.15585/mmwr.mm6915e6.</mixed-citation><mixed-citation xml:lang="en">CDC COVID-19 Response Team. Characteristics of health care personnel with COVID-19: United States, February 12–April 9, 2020. Morbidity and Mortality Weekly Report. 2020 Apr 17; 69: 477–81. doi: 10.15585/mmwr.mm6915e6.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lazzerini M., Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Glob Health. 2020 May;8(5):e641–e642.doi: 10.1016/S2214-109X(20)30110-8.</mixed-citation><mixed-citation xml:lang="en">Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Glob Health. 2020 May;8(5):e641–e642. doi: 10.1016/S2214-109X(20)30110-8.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen L.Н., Drew D.А., Joshi A.D., et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020 Sep;5(9):e475–e483. doi: 10.1016/S2468-2667(20)30164-X.</mixed-citation><mixed-citation xml:lang="en">Nguyen LН, Drew DА, Joshi AD, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020 Sep;5(9):e475–e483. doi: 10.1016/S2468-2667(20)30164-X.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sellmeij. J Med Life. 2022 Sep;15(9):1119–1128. doi: 10.25122/jml-2022-0126.</mixed-citation><mixed-citation xml:lang="en">Sellmeier AC, Elsner A, Niedergassel T, et al. COVID-19 after the first wave of the pandemic among employees from a German university hospital: prevalence and questionnaire data. J Med Life. 2022 Sep;15(9):1119–1128. doi: 10.25122/jml-2022-0126.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Covid-19: protecting health-care workers. Lancet. 2020 Mar 21;395(10228):922. doi: 10.1016/S0140-6736(20)30644-9.</mixed-citation><mixed-citation xml:lang="en">Covid-19: protecting health-care workers. Lancet. 2020 Mar 21;395(10228):922. doi: 10.1016/S0140-6736(20)30644-9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Новая коронавирусная инфекция COVID-19: профессиональные аспекты сохранения здоровья и безопасности медицинских работников: методические рекомендации. И. В. Бухтияров, Ю. Ю. Горблянский, ред.. М. АМТ, ФГБНУ «НИИ МТ», 2021.</mixed-citation><mixed-citation xml:lang="en">Novaya koronavirusnaya infektsiya COVID-19: professional’nyye aspekty sokhraneniya zdorov’ya i bezopasnosti meditsinskikh rabotnikov: metodicheskiye rekomendatsii. Ed.: I.V. Bukhtiyarov, Yu.Yu. Gorblyansky. M. AMT, FGBNU «NII MT», 2021 (In Russ)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Богорjия. 2020. № 4. С. 3–9.</mixed-citation><mixed-citation xml:lang="en">Bogorodskaya YeM. Impact of COVID-19 pandemia on tuberculosis control in Moscow city. Tuberculosis and socially significant diseases. 2020; 4:3–9 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Богородская Е. М., Котова Е. А. Организация противотуберкулезной работы в г. Москве в период пандемии новой коронавирусной инфекции COVID-19. Противотуберкулезная работа в городе Москве в период пандемии COVID-19. 2020 г. Е. М. Богородская, ред. М.: МНПЦБТ. 2021. C.16–30.</mixed-citation><mixed-citation xml:lang="en">Bogorodskaya YeM, Kotova YeA. Organizatsiya protivotuberkuleznoy raboty v g. Moskve v period pandemii novoy koronavirusnoy infektsii COVID-19. Protivotuberkuleznaya rabota v gorode Moskve v period pandemii COVID-19. 2020, Ed: YeM Bogorodskyа, Moscow: MNPTSBT; 2021.16–30 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Пахомов Д. В. Вакцинопрофилактика COVID-19. Практическая пульмонология. 2020, № 3. С. 74–79 https://cyberleninka.ru/article/n/vaktsinoprofilaktika-covid-19.</mixed-citation><mixed-citation xml:lang="en">Pakhomov DV. Vaccine Prevention of COVID-19. Prakticheskaya pulmonologiya. 2020. 3. 74–79 Available at: https://cyberleninka.ru/article/n/vaktsinoprofilaktika-covid-19. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Logja randomized controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671–681. doi: 10.1016/S0140-6736(21)00234-8.</mixed-citation><mixed-citation xml:lang="en">Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomized controlled phase 3 trial in Russia. Lancet. 2021; (published online Feb 2.) https://doi.org/10.1016/S0140-6736(21)00234-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Богородская Е. М., Ноздреватых И. В., Христофорова Е. Л. и др. Влияние иммунизации противокоронавирусными вакцинами на заболеваемость COVID-19 сотрудников крупного противотуберкулезного учреждения города Москвы. Эпидемиология и Вакцинопрофилактика. 2022;21(2): 46–58. https:// doi:10.31631/2073-3046-2022-21-2-46-58.</mixed-citation><mixed-citation xml:lang="en">Bogorodskaya YeM, Nozdrevatykh IV, Khristoforova EL, et al. The Impact of Immunization with Anti-Coronavirus Vaccines on the Incidence of COVID-19 in Employees of a Large. Epidemiology and Vaccinal Prevention. 2022;21(2): 46–58. (In Russ). doi:10.31631/2073-3046-2022-21-2-46-58.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Доступно на: https://coronavirus-graph.ru/rossiya/moskva Дата обращения: 21.07.2023.</mixed-citation><mixed-citation xml:lang="en">Available at: https://coronavirus-graph.ru/rossiya/moskva Access date: 21.07.2023 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Пшеничная Н. Ю., Лизинфельд И. А., Журавлёв Г.Ю. и др. Эпидемический процесс COVID-19 в Российской Федерации: промежуточные итоги. Сообщение 1. Инфекционные болезни. 2020; 18(3): 7–14. DOI: 10.20953/1729-9225-2020-3-7-14.</mixed-citation><mixed-citation xml:lang="en">Pshenichnaya NYu, Lizinfeld IA, Zhuravlev GYu, et al. Epidemic process of COVID-19 in the Russian Federation: interim results. 1th report. Infekc. bolezni (Infectious diseases). 2020; 18(3): 7–14. (In Russian). DOI: 10.20953/1729-9225-2020-3-7-14.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cj3(2):120–136. doi: 10.7326/M20-1632.</mixed-citation><mixed-citation xml:lang="en">Chou R, Dana T, Buckley D, et al. Epidemiology of and risk factors for coronavirus infection in health care workers: a living rapid review. Ann Intern Med. 2020 Jul 21;173(2):120–136. doi: 10.7326/M20-1632.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Платоjнального риска // Эпидемиология и Вакцинопрофилактика. 2021;20(2):4–11. https://doi.org/10.31631/2073-3046-2021-20-2-4-11.</mixed-citation><mixed-citation xml:lang="en">Platonova TA, Golubkova AA, Tutelyan AV, et al. The Incidence of COVID-19 Medical Workers. The Issues of Biosafety and Occupational risk Factors. Epidemiology and Vaccinal Prevention. 2021;20(2):4–11 (In Russ). https://doi.org/10.31631/2073-3046-2021-20-2-4-11.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
